二线抗结核药物暴露值,可预测多药耐药结核病治疗中的不良事件
Sainan Wang1, Lina Davies Forsman2, Chunhua Xu3
1Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, China.
概括
这项研究确定了与多药耐药结核病 (MDR-TB) 治疗中的不良事件 (AE) 相关的药物暴露值. 这些发现有助于调整药物剂量,以尽量减少MDR-TB治疗期间的风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 临床药房 临床药房
背景情况:
- 多抗药结核病 (MDR-TB) 的标准化治疗涉及多种药物,增加不良事件 (AE) 的风险.
- 了解药物暴露和AEs之间的关系对于优化MDR-TB治疗方案至关重要.
- 确定AE的预测值可以指导剂量调整并提高患者的安全性.
研究的目的:
- 调查在标准化MDR-TB治疗期间药物暴露和AEs之间的关联.
- 确定常见AEs的预测性药物暴露值.
- 建立在MDR-TB治疗中剂量优化的基础.
主要方法:
- 在中国进行了一项前性,观察性多中心研究,涉及接受标准化MDR-TB治疗的参与者.
- 监测了不良事件 (AEs),并分析了它们与药物暴露的关系,特别是药物度-时间曲线 (AUC0-24h) 下的区域.
- 增强分类和回归树 (CART) 模型被用于确定AE预测药物暴露值,随后进行外部验证.
主要成果:
- 在197名参与者中,有124人 (62.9%) 经历过至少一个副作用,其中15人 (7.6%) 报告严重的副作用.
- 在药物暴露和AEs之间发现了显著的关联,包括贝达基林代谢物M2,莫西弗洛克萨,线索立德和环素.
- 确定了可预测AE的特定AUC0-24h值:贝达基林M2的3.2 mg·h/l,莫西素的49.3 mg·h/l,莱因佐利德的119.3 mg·h/l,环素的718.7 mg·h/l.
结论:
- 这项研究成功地确定了药物暴露值,预测了治疗MDR-TB的患者的不良事件.
- 确定的值为未来的临床试验提供了有价值的数据,重点是剂量调整策略.
- 实施这些值可以帮助最大限度地降低副作用的风险,并改善MDR-TB患者的治疗结果.
相关概念视频
01:28Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
01:31Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
01:26Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
01:29Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
01:28Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
01:20Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K